Androgen deprivation therapy induces androgen receptor-dependent upregulation of Egr1 in prostate cancers

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 6, 2014, Pages 2883-2893

  Xu, Bin ^a   Tang, Gusheng ^a   Xiao, Chengwu ^a   Wang, Linhui ^a   Yang, Qing ^a   Sun, Yinghao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Androgen deprivation treatmen; Androgen receptor; Egr1; Id1; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AR PROTEIN, HUMAN; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, HUMAN; ID1 PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION 1; SMALL INTERFERING RNA;

AGED; BIOSYNTHESIS; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UPREGULATION; VERY ELDERLY; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BLOTTING, WESTERN; CELL LINE, TUMOR; DISEASE PROGRESSION; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; UP-REGULATION;

EID: 84904268174     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gronberg H. Prostate cancer epidemiology. Lancet 2003; 361: 859-864.
2. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
3. Dreicer R, Gleave M, Kibel AS, Thrasher JB and Moul JW. Targeting the androgen receptor--theory and practice. Urology 2011; 78: S482-484.
4. Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, Siddiqui J, Sam L, Anstett M, Mehra R, Prensner JR, Palanisamy N, Ryslik GA, Vandin F, Raphael BJ, Kunju LP, Rhodes DR, Pienta KJ, Chinnaiyan AM and Tomlins SA. The mutational landscape of lethal castration-resistant prostate cancer. Nature 2012; 487: 239-243.
5. Kim HJ, Hong JM, Yoon KA, Kim N, Cho DW, Choi JY, Lee IK and Kim SY. Early growth response 2 negatively modulates osteoclast differentiation through upregulation of Id helix-loop-helix proteins. Bone 2012; 51: 643-650.
6. Abdulkadir SA, Carbone JM, Naughton CK, Humphrey PA, Catalona WJ and Milbrandt J. Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma. Hum Pathol 2001; 32: 935-939.
7. Svaren J, Ehrig T, Abdulkadir SA, Ehrengruber MU, Watson MA and Milbrandt J. EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J Biol Chem 2000; 275: 38524-38531.
8. Zheng L, Pu J, Jiang G, Weng M, He J, Mei H, Hou X and Tong Q. Abnormal expression of early growth response 1 in gastric cancer: association with tumor invasion, metastasis and heparanase transcription. Pathol Int 2010; 60: 268-277.
9. Xu B, Sun Y, Tang G, Xu C, Wang L, Zhang Y and Ji J. Id-1 expression in androgen-dependent prostate cancer is negatively regulated by androgen through androgen receptor. Cancer Lett 2009; 278: 220-229.
10. Tournay O and Benezra R. Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1. Mol Cell Biol 1996; 16: 2418-2430.
11. Parra E, Ortega A and Saenz L. Down-regulation of Egr-1 by siRNA inhibits growth of human prostate carcinoma cell line PC-3. Oncol Rep 2009; 22: 1513-1518.
12. Mora GR, Olivier KR, Cheville JC, Mitchell RF Jr, Lingle WL and Tindall DJ. The cytoskeleton differentially localizes the early growth response gene-1 protein in cancer and benign cells of the prostate. Mol Cancer Res 2004; 2: 115-128.
13. Eid MA, Kumar MV, Iczkowski KA, Bostwick DG and Tindall DJ. Expression of early growth response genes in human prostate cancer. Cancer Res 1998; 58: 2461-2468.
14. Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, Wu T, Regan MM, Meyer CA, Carroll JS, Manrai AK, Janne OA, Balk SP, Mehra R, Han B, Chinnaiyan AM, Rubin MA, True L, Fiorentino M, Fiore C, Loda M, Kantoff PW, Liu XS and Brown M. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 2009; 138: 245-256.
15. Shaw G, Price AM, Ktori E, Bisson I, Purkis PE, McFaul S, Oliver RT and Prowse DM. Hedgehog signalling in androgen independent prostate cancer. Eur Urol 2008; 54: 1333-1343.
16. Wolff DW, Xie Y, Deng C, Gatalica Z, Yang M, Wang B, Wang J, Lin MF, Abel PW and Tu Y. Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth. Int J Cancer 2012; 130: 1521-1531.
17. Bhattacharyya S, Fang F, Tourtellotte W and Varga J. Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis). J Pathol 2013; 229: 286-297.
18. Kang HS, Ock J, Lee HJ, Lee YJ, Kwon BM and Hong SH. Early growth response protein 1 upregulation and nuclear translocation by 2'-benzoyloxycinnamaldehyde induces prostate cancer cell death. Cancer Lett 2013; 329: 217-227.
19. Arora S, Wang Y, Jia Z, Vardar-Sengul S, Munawar A, Doctor KS, Birrer M, McClelland M, Adamson E and Mercola D. Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip. Genome Biol 2008; 9: R166.
20. Baron V, Adamson ED, Calogero A, Ragona G and Mercola D. The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther 2006; 13: 115-124.
21. Kataoka F, Tsuda H, Arao T, Nishimura S, Tanaka H, Nomura H, Chiyoda T, Hirasawa A, Akahane T, Nishio H, Nishio K and Aoki D. EGRI and FOSB gene expressions in cancer stroma are independent prognostic indicators for epithelial ovarian cancer receiving standard therapy. Genes Chromosomes Cancer 2012; 51: 300-312.
22. Gregg J and Fraizer G. Transcriptional Regulation of EGR1 by EGF and the ERK Signaling Pathway in Prostate Cancer Cells. Genes Cancer 2011; 2: 900-909.
23. Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED and Mercola D. Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes. J Biol Chem 2003; 278: 11802-11810.
24. Abdulkadir SA, Qu Z, Garabedian E, Song SK, Peters TJ, Svaren J, Carbone JM, Naughton CK, Catalona WJ, Ackerman JJ, Gordon JI, Humphrey PA and Milbrandt J. Impaired prostate tumorigenesis in Egr1-deficient mice. Nat Med 2001; 7: 101-107.
25. Jones AC, Trujillo KA, Phillips GK, Fleet TM, Murton JK, Severns V, Shah SK, Davis MS, Smith AY, Griffith JK, Fischer EG and Bisoffi M. Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization. Prostate 2012; 72: 1159-1170.
26. Yang SZ, Eltoum IA and Abdulkadir SA. Enhanced EGR1 activity promotes the growth of prostate cancer cells in an androgen-depleted environment. J Cell Biochem 2006; 97: 1292-1299.
27. Cheng YJ, Tsai JW, Hsieh KC, Yang YC, Chen YJ, Huang MS and Yuan SS. Id1 promotes lung cancer cell proliferation and tumor growth through Akt-related pathway. Cancer Lett 2011; 307: 191-199.
28. Forootan SS, Wong YC, Dodson A, Wang X, Lin K, Smith PH, Foster CS and Ke Y. Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer. Hum Pathol 2007; 38: 1321-1329.
29. Lin JC, Chang SY, Hsieh DS, Lee CF and Yu DS. Modulation of mitogen-activated protein kinase cascades by differentiation-1 protein: acquired drug resistance of hormone independent prostate cancer cells. J Urol 2005; 174: 2022-2026.
30. Ling MT, Wang X, Lee DT, Tam PC, Tsao SW and Wong YC. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R). Carcinogenesis 2004; 25: 517-525.
31. Passiatore G, Gentilella A, Rom S, Pacifici M, Bergonzini V and Peruzzi F. Induction of Id-1 by FGF-2 involves activity of EGR-1 and sensitizes neuroblastoma cells to cell death. J Cell Physiol 2011; 226: 1763-1770.